Global Dermatophytic Onychomycosis Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
According to our (Global Info Research) latest study, the global Dermatophytic Onychomycosis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
This report is a detailed and comprehensive analysis for global Dermatophytic Onychomycosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Dermatophytic Onychomycosis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dermatophytic Onychomycosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dermatophytic Onychomycosis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, GSK, Novartis, Pfizer and Bausch Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Dermatophytic Onychomycosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Dermatophytic Onychomycosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dermatophytic Onychomycosis, with revenue, gross margin and global market share of Dermatophytic Onychomycosis from 2018 to 2023.
Chapter 3, the Dermatophytic Onychomycosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Dermatophytic Onychomycosis market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatophytic Onychomycosis.
Chapter 13, to describe Dermatophytic Onychomycosis research findings and conclusion.
According to our (Global Info Research) latest study, the global Dermatophytic Onychomycosis market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
This report is a detailed and comprehensive analysis for global Dermatophytic Onychomycosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Dermatophytic Onychomycosis market size and forecasts, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Dermatophytic Onychomycosis market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dermatophytic Onychomycosis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dermatophytic Onychomycosis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, GSK, Novartis, Pfizer and Bausch Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Dermatophytic Onychomycosis market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Oral Medicine
- External Medicine
- Age Under 18
- Age 18-50
- Age Above 50
- Johnson & Johnson
- GSK
- Novartis
- Pfizer
- Bausch Health
- Kaken Pharmaceutical
- Galderma
- Sanofi
- Allergan
- Merz Pharma
- Xiuzheng Pharmaceutical
- Letai
- Qilu Pharmaceutical
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Dermatophytic Onychomycosis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dermatophytic Onychomycosis, with revenue, gross margin and global market share of Dermatophytic Onychomycosis from 2018 to 2023.
Chapter 3, the Dermatophytic Onychomycosis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Dermatophytic Onychomycosis market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Dermatophytic Onychomycosis.
Chapter 13, to describe Dermatophytic Onychomycosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Dermatophytic Onychomycosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dermatophytic Onychomycosis by Type
1.3.1 Overview: Global Dermatophytic Onychomycosis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Dermatophytic Onychomycosis Consumption Value Market Share by Type in 2022
1.3.3 Oral Medicine
1.3.4 External Medicine
1.4 Global Dermatophytic Onychomycosis Market by Application
1.4.1 Overview: Global Dermatophytic Onychomycosis Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Age Under
1.4.3 Age 18-50
1.4.4 Age Above
1.5 Global Dermatophytic Onychomycosis Market Size & Forecast
1.6 Global Dermatophytic Onychomycosis Market Size and Forecast by Region
1.6.1 Global Dermatophytic Onychomycosis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Dermatophytic Onychomycosis Market Size by Region, (2018-2029)
1.6.3 North America Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.4 Europe Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.6 South America Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Dermatophytic Onychomycosis Product and Solutions
2.1.4 Johnson & Johnson Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Dermatophytic Onychomycosis Product and Solutions
2.2.4 GSK Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Dermatophytic Onychomycosis Product and Solutions
2.3.4 Novartis Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Dermatophytic Onychomycosis Product and Solutions
2.4.4 Pfizer Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Dermatophytic Onychomycosis Product and Solutions
2.5.4 Bausch Health Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bausch Health Recent Developments and Future Plans
2.6 Kaken Pharmaceutical
2.6.1 Kaken Pharmaceutical Details
2.6.2 Kaken Pharmaceutical Major Business
2.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.6.4 Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kaken Pharmaceutical Recent Developments and Future Plans
2.7 Galderma
2.7.1 Galderma Details
2.7.2 Galderma Major Business
2.7.3 Galderma Dermatophytic Onychomycosis Product and Solutions
2.7.4 Galderma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Galderma Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Dermatophytic Onychomycosis Product and Solutions
2.8.4 Sanofi Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Dermatophytic Onychomycosis Product and Solutions
2.9.4 Allergan Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Merz Pharma
2.10.1 Merz Pharma Details
2.10.2 Merz Pharma Major Business
2.10.3 Merz Pharma Dermatophytic Onychomycosis Product and Solutions
2.10.4 Merz Pharma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merz Pharma Recent Developments and Future Plans
2.11 Xiuzheng Pharmaceutical
2.11.1 Xiuzheng Pharmaceutical Details
2.11.2 Xiuzheng Pharmaceutical Major Business
2.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.11.4 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
2.12 Letai
2.12.1 Letai Details
2.12.2 Letai Major Business
2.12.3 Letai Dermatophytic Onychomycosis Product and Solutions
2.12.4 Letai Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Letai Recent Developments and Future Plans
2.13 Qilu Pharmaceutical
2.13.1 Qilu Pharmaceutical Details
2.13.2 Qilu Pharmaceutical Major Business
2.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.13.4 Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Qilu Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Dermatophytic Onychomycosis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Dermatophytic Onychomycosis by Company Revenue
3.2.2 Top 3 Dermatophytic Onychomycosis Players Market Share in 2022
3.2.3 Top 6 Dermatophytic Onychomycosis Players Market Share in 2022
3.3 Dermatophytic Onychomycosis Market: Overall Company Footprint Analysis
3.3.1 Dermatophytic Onychomycosis Market: Region Footprint
3.3.2 Dermatophytic Onychomycosis Market: Company Product Type Footprint
3.3.3 Dermatophytic Onychomycosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Dermatophytic Onychomycosis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Dermatophytic Onychomycosis Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2023)
5.2 Global Dermatophytic Onychomycosis Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
6.2 North America Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
6.3 North America Dermatophytic Onychomycosis Market Size by Country
6.3.1 North America Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
6.3.2 United States Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
6.3.3 Canada Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
6.3.4 Mexico Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
7.2 Europe Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
7.3 Europe Dermatophytic Onychomycosis Market Size by Country
7.3.1 Europe Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
7.3.2 Germany Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.3 France Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.5 Russia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.6 Italy Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Region
8.3.1 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2018-2029)
8.3.2 China Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.3 Japan Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.4 South Korea Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.5 India Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.7 Australia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
9.2 South America Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
9.3 South America Dermatophytic Onychomycosis Market Size by Country
9.3.1 South America Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
9.3.2 Brazil Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
9.3.3 Argentina Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country
10.3.1 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
10.3.2 Turkey Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10.3.4 UAE Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Dermatophytic Onychomycosis Market Drivers
11.2 Dermatophytic Onychomycosis Market Restraints
11.3 Dermatophytic Onychomycosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Dermatophytic Onychomycosis Industry Chain
12.2 Dermatophytic Onychomycosis Upstream Analysis
12.3 Dermatophytic Onychomycosis Midstream Analysis
12.4 Dermatophytic Onychomycosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Dermatophytic Onychomycosis
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Dermatophytic Onychomycosis by Type
1.3.1 Overview: Global Dermatophytic Onychomycosis Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Dermatophytic Onychomycosis Consumption Value Market Share by Type in 2022
1.3.3 Oral Medicine
1.3.4 External Medicine
1.4 Global Dermatophytic Onychomycosis Market by Application
1.4.1 Overview: Global Dermatophytic Onychomycosis Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Age Under
1.4.3 Age 18-50
1.4.4 Age Above
1.5 Global Dermatophytic Onychomycosis Market Size & Forecast
1.6 Global Dermatophytic Onychomycosis Market Size and Forecast by Region
1.6.1 Global Dermatophytic Onychomycosis Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Dermatophytic Onychomycosis Market Size by Region, (2018-2029)
1.6.3 North America Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.4 Europe Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.6 South America Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Dermatophytic Onychomycosis Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Dermatophytic Onychomycosis Product and Solutions
2.1.4 Johnson & Johnson Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Johnson & Johnson Recent Developments and Future Plans
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Dermatophytic Onychomycosis Product and Solutions
2.2.4 GSK Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Dermatophytic Onychomycosis Product and Solutions
2.3.4 Novartis Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Dermatophytic Onychomycosis Product and Solutions
2.4.4 Pfizer Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer Recent Developments and Future Plans
2.5 Bausch Health
2.5.1 Bausch Health Details
2.5.2 Bausch Health Major Business
2.5.3 Bausch Health Dermatophytic Onychomycosis Product and Solutions
2.5.4 Bausch Health Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bausch Health Recent Developments and Future Plans
2.6 Kaken Pharmaceutical
2.6.1 Kaken Pharmaceutical Details
2.6.2 Kaken Pharmaceutical Major Business
2.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.6.4 Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kaken Pharmaceutical Recent Developments and Future Plans
2.7 Galderma
2.7.1 Galderma Details
2.7.2 Galderma Major Business
2.7.3 Galderma Dermatophytic Onychomycosis Product and Solutions
2.7.4 Galderma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Galderma Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Dermatophytic Onychomycosis Product and Solutions
2.8.4 Sanofi Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Allergan
2.9.1 Allergan Details
2.9.2 Allergan Major Business
2.9.3 Allergan Dermatophytic Onychomycosis Product and Solutions
2.9.4 Allergan Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan Recent Developments and Future Plans
2.10 Merz Pharma
2.10.1 Merz Pharma Details
2.10.2 Merz Pharma Major Business
2.10.3 Merz Pharma Dermatophytic Onychomycosis Product and Solutions
2.10.4 Merz Pharma Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Merz Pharma Recent Developments and Future Plans
2.11 Xiuzheng Pharmaceutical
2.11.1 Xiuzheng Pharmaceutical Details
2.11.2 Xiuzheng Pharmaceutical Major Business
2.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.11.4 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
2.12 Letai
2.12.1 Letai Details
2.12.2 Letai Major Business
2.12.3 Letai Dermatophytic Onychomycosis Product and Solutions
2.12.4 Letai Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Letai Recent Developments and Future Plans
2.13 Qilu Pharmaceutical
2.13.1 Qilu Pharmaceutical Details
2.13.2 Qilu Pharmaceutical Major Business
2.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
2.13.4 Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Qilu Pharmaceutical Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Dermatophytic Onychomycosis Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Dermatophytic Onychomycosis by Company Revenue
3.2.2 Top 3 Dermatophytic Onychomycosis Players Market Share in 2022
3.2.3 Top 6 Dermatophytic Onychomycosis Players Market Share in 2022
3.3 Dermatophytic Onychomycosis Market: Overall Company Footprint Analysis
3.3.1 Dermatophytic Onychomycosis Market: Region Footprint
3.3.2 Dermatophytic Onychomycosis Market: Company Product Type Footprint
3.3.3 Dermatophytic Onychomycosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Dermatophytic Onychomycosis Consumption Value and Market Share by Type (2018-2023)
4.2 Global Dermatophytic Onychomycosis Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2023)
5.2 Global Dermatophytic Onychomycosis Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
6.2 North America Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
6.3 North America Dermatophytic Onychomycosis Market Size by Country
6.3.1 North America Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
6.3.2 United States Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
6.3.3 Canada Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
6.3.4 Mexico Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
7.2 Europe Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
7.3 Europe Dermatophytic Onychomycosis Market Size by Country
7.3.1 Europe Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
7.3.2 Germany Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.3 France Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.5 Russia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
7.3.6 Italy Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Dermatophytic Onychomycosis Market Size by Region
8.3.1 Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2018-2029)
8.3.2 China Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.3 Japan Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.4 South Korea Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.5 India Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
8.3.7 Australia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
9.2 South America Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
9.3 South America Dermatophytic Onychomycosis Market Size by Country
9.3.1 South America Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
9.3.2 Brazil Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
9.3.3 Argentina Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Dermatophytic Onychomycosis Market Size by Country
10.3.1 Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2018-2029)
10.3.2 Turkey Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
10.3.4 UAE Dermatophytic Onychomycosis Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Dermatophytic Onychomycosis Market Drivers
11.2 Dermatophytic Onychomycosis Market Restraints
11.3 Dermatophytic Onychomycosis Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Dermatophytic Onychomycosis Industry Chain
12.2 Dermatophytic Onychomycosis Upstream Analysis
12.3 Dermatophytic Onychomycosis Midstream Analysis
12.4 Dermatophytic Onychomycosis Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dermatophytic Onychomycosis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Dermatophytic Onychomycosis Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Dermatophytic Onychomycosis Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Dermatophytic Onychomycosis Product and Solutions
Table 8. Johnson & Johnson Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. GSK Company Information, Head Office, and Major Competitors
Table 11. GSK Major Business
Table 12. GSK Dermatophytic Onychomycosis Product and Solutions
Table 13. GSK Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. GSK Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Dermatophytic Onychomycosis Product and Solutions
Table 18. Novartis Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Dermatophytic Onychomycosis Product and Solutions
Table 23. Pfizer Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Bausch Health Company Information, Head Office, and Major Competitors
Table 26. Bausch Health Major Business
Table 27. Bausch Health Dermatophytic Onychomycosis Product and Solutions
Table 28. Bausch Health Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bausch Health Recent Developments and Future Plans
Table 30. Kaken Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Kaken Pharmaceutical Major Business
Table 32. Kaken Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 33. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Kaken Pharmaceutical Recent Developments and Future Plans
Table 35. Galderma Company Information, Head Office, and Major Competitors
Table 36. Galderma Major Business
Table 37. Galderma Dermatophytic Onychomycosis Product and Solutions
Table 38. Galderma Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Galderma Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Dermatophytic Onychomycosis Product and Solutions
Table 43. Sanofi Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. Allergan Company Information, Head Office, and Major Competitors
Table 46. Allergan Major Business
Table 47. Allergan Dermatophytic Onychomycosis Product and Solutions
Table 48. Allergan Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Allergan Recent Developments and Future Plans
Table 50. Merz Pharma Company Information, Head Office, and Major Competitors
Table 51. Merz Pharma Major Business
Table 52. Merz Pharma Dermatophytic Onychomycosis Product and Solutions
Table 53. Merz Pharma Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Merz Pharma Recent Developments and Future Plans
Table 55. Xiuzheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Xiuzheng Pharmaceutical Major Business
Table 57. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 58. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Xiuzheng Pharmaceutical Recent Developments and Future Plans
Table 60. Letai Company Information, Head Office, and Major Competitors
Table 61. Letai Major Business
Table 62. Letai Dermatophytic Onychomycosis Product and Solutions
Table 63. Letai Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Letai Recent Developments and Future Plans
Table 65. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 66. Qilu Pharmaceutical Major Business
Table 67. Qilu Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 68. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Qilu Pharmaceutical Recent Developments and Future Plans
Table 70. Global Dermatophytic Onychomycosis Revenue (USD Million) by Players (2018-2023)
Table 71. Global Dermatophytic Onychomycosis Revenue Share by Players (2018-2023)
Table 72. Breakdown of Dermatophytic Onychomycosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Dermatophytic Onychomycosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Dermatophytic Onychomycosis Players
Table 75. Dermatophytic Onychomycosis Market: Company Product Type Footprint
Table 76. Dermatophytic Onychomycosis Market: Company Product Application Footprint
Table 77. Dermatophytic Onychomycosis New Market Entrants and Barriers to Market Entry
Table 78. Dermatophytic Onychomycosis Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Dermatophytic Onychomycosis Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Dermatophytic Onychomycosis Consumption Value Share by Type (2018-2023)
Table 81. Global Dermatophytic Onychomycosis Consumption Value Forecast by Type (2024-2029)
Table 82. Global Dermatophytic Onychomycosis Consumption Value by Application (2018-2023)
Table 83. Global Dermatophytic Onychomycosis Consumption Value Forecast by Application (2024-2029)
Table 84. North America Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Dermatophytic Onychomycosis Raw Material
Table 115. Key Suppliers of Dermatophytic Onychomycosis Raw Materials
Table 1. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Dermatophytic Onychomycosis Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Dermatophytic Onychomycosis Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Dermatophytic Onychomycosis Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 6. Johnson & Johnson Major Business
Table 7. Johnson & Johnson Dermatophytic Onychomycosis Product and Solutions
Table 8. Johnson & Johnson Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Johnson & Johnson Recent Developments and Future Plans
Table 10. GSK Company Information, Head Office, and Major Competitors
Table 11. GSK Major Business
Table 12. GSK Dermatophytic Onychomycosis Product and Solutions
Table 13. GSK Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. GSK Recent Developments and Future Plans
Table 15. Novartis Company Information, Head Office, and Major Competitors
Table 16. Novartis Major Business
Table 17. Novartis Dermatophytic Onychomycosis Product and Solutions
Table 18. Novartis Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis Recent Developments and Future Plans
Table 20. Pfizer Company Information, Head Office, and Major Competitors
Table 21. Pfizer Major Business
Table 22. Pfizer Dermatophytic Onychomycosis Product and Solutions
Table 23. Pfizer Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pfizer Recent Developments and Future Plans
Table 25. Bausch Health Company Information, Head Office, and Major Competitors
Table 26. Bausch Health Major Business
Table 27. Bausch Health Dermatophytic Onychomycosis Product and Solutions
Table 28. Bausch Health Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bausch Health Recent Developments and Future Plans
Table 30. Kaken Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Kaken Pharmaceutical Major Business
Table 32. Kaken Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 33. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Kaken Pharmaceutical Recent Developments and Future Plans
Table 35. Galderma Company Information, Head Office, and Major Competitors
Table 36. Galderma Major Business
Table 37. Galderma Dermatophytic Onychomycosis Product and Solutions
Table 38. Galderma Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Galderma Recent Developments and Future Plans
Table 40. Sanofi Company Information, Head Office, and Major Competitors
Table 41. Sanofi Major Business
Table 42. Sanofi Dermatophytic Onychomycosis Product and Solutions
Table 43. Sanofi Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Sanofi Recent Developments and Future Plans
Table 45. Allergan Company Information, Head Office, and Major Competitors
Table 46. Allergan Major Business
Table 47. Allergan Dermatophytic Onychomycosis Product and Solutions
Table 48. Allergan Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Allergan Recent Developments and Future Plans
Table 50. Merz Pharma Company Information, Head Office, and Major Competitors
Table 51. Merz Pharma Major Business
Table 52. Merz Pharma Dermatophytic Onychomycosis Product and Solutions
Table 53. Merz Pharma Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Merz Pharma Recent Developments and Future Plans
Table 55. Xiuzheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 56. Xiuzheng Pharmaceutical Major Business
Table 57. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 58. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Xiuzheng Pharmaceutical Recent Developments and Future Plans
Table 60. Letai Company Information, Head Office, and Major Competitors
Table 61. Letai Major Business
Table 62. Letai Dermatophytic Onychomycosis Product and Solutions
Table 63. Letai Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Letai Recent Developments and Future Plans
Table 65. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 66. Qilu Pharmaceutical Major Business
Table 67. Qilu Pharmaceutical Dermatophytic Onychomycosis Product and Solutions
Table 68. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Qilu Pharmaceutical Recent Developments and Future Plans
Table 70. Global Dermatophytic Onychomycosis Revenue (USD Million) by Players (2018-2023)
Table 71. Global Dermatophytic Onychomycosis Revenue Share by Players (2018-2023)
Table 72. Breakdown of Dermatophytic Onychomycosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Dermatophytic Onychomycosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Dermatophytic Onychomycosis Players
Table 75. Dermatophytic Onychomycosis Market: Company Product Type Footprint
Table 76. Dermatophytic Onychomycosis Market: Company Product Application Footprint
Table 77. Dermatophytic Onychomycosis New Market Entrants and Barriers to Market Entry
Table 78. Dermatophytic Onychomycosis Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Dermatophytic Onychomycosis Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Dermatophytic Onychomycosis Consumption Value Share by Type (2018-2023)
Table 81. Global Dermatophytic Onychomycosis Consumption Value Forecast by Type (2024-2029)
Table 82. Global Dermatophytic Onychomycosis Consumption Value by Application (2018-2023)
Table 83. Global Dermatophytic Onychomycosis Consumption Value Forecast by Application (2024-2029)
Table 84. North America Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Dermatophytic Onychomycosis Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Dermatophytic Onychomycosis Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Dermatophytic Onychomycosis Raw Material
Table 115. Key Suppliers of Dermatophytic Onychomycosis Raw Materials
LIST OF FIGURES
Figure 1. Dermatophytic Onychomycosis Picture
Figure 2. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dermatophytic Onychomycosis Consumption Value Market Share by Type in 2022
Figure 4. Oral Medicine
Figure 5. External Medicine
Figure 6. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Dermatophytic Onychomycosis Consumption Value Market Share by Application in 2022
Figure 8. Age Under 18 Picture
Figure 9. Age 18-50 Picture
Figure 10. Age Above 50 Picture
Figure 11. Global Dermatophytic Onychomycosis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Dermatophytic Onychomycosis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Dermatophytic Onychomycosis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Dermatophytic Onychomycosis Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Dermatophytic Onychomycosis Consumption Value Market Share by Region in 2022
Figure 16. North America Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Dermatophytic Onychomycosis Revenue Share by Players in 2022
Figure 22. Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Dermatophytic Onychomycosis Market Share in 2022
Figure 24. Global Top 6 Players Dermatophytic Onychomycosis Market Share in 2022
Figure 25. Global Dermatophytic Onychomycosis Consumption Value Share by Type (2018-2023)
Figure 26. Global Dermatophytic Onychomycosis Market Share Forecast by Type (2024-2029)
Figure 27. Global Dermatophytic Onychomycosis Consumption Value Share by Application (2018-2023)
Figure 28. Global Dermatophytic Onychomycosis Market Share Forecast by Application (2024-2029)
Figure 29. North America Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 39. France Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Region (2018-2029)
Figure 46. China Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 49. India Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 63. Dermatophytic Onychomycosis Market Drivers
Figure 64. Dermatophytic Onychomycosis Market Restraints
Figure 65. Dermatophytic Onychomycosis Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dermatophytic Onychomycosis in 2022
Figure 68. Manufacturing Process Analysis of Dermatophytic Onychomycosis
Figure 69. Dermatophytic Onychomycosis Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Dermatophytic Onychomycosis Picture
Figure 2. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Dermatophytic Onychomycosis Consumption Value Market Share by Type in 2022
Figure 4. Oral Medicine
Figure 5. External Medicine
Figure 6. Global Dermatophytic Onychomycosis Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Dermatophytic Onychomycosis Consumption Value Market Share by Application in 2022
Figure 8. Age Under 18 Picture
Figure 9. Age 18-50 Picture
Figure 10. Age Above 50 Picture
Figure 11. Global Dermatophytic Onychomycosis Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Dermatophytic Onychomycosis Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Dermatophytic Onychomycosis Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Dermatophytic Onychomycosis Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Dermatophytic Onychomycosis Consumption Value Market Share by Region in 2022
Figure 16. North America Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Dermatophytic Onychomycosis Revenue Share by Players in 2022
Figure 22. Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Dermatophytic Onychomycosis Market Share in 2022
Figure 24. Global Top 6 Players Dermatophytic Onychomycosis Market Share in 2022
Figure 25. Global Dermatophytic Onychomycosis Consumption Value Share by Type (2018-2023)
Figure 26. Global Dermatophytic Onychomycosis Market Share Forecast by Type (2024-2029)
Figure 27. Global Dermatophytic Onychomycosis Consumption Value Share by Application (2018-2023)
Figure 28. Global Dermatophytic Onychomycosis Market Share Forecast by Application (2024-2029)
Figure 29. North America Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 39. France Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Dermatophytic Onychomycosis Consumption Value Market Share by Region (2018-2029)
Figure 46. China Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 49. India Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Dermatophytic Onychomycosis Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Dermatophytic Onychomycosis Consumption Value (2018-2029) & (USD Million)
Figure 63. Dermatophytic Onychomycosis Market Drivers
Figure 64. Dermatophytic Onychomycosis Market Restraints
Figure 65. Dermatophytic Onychomycosis Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Dermatophytic Onychomycosis in 2022
Figure 68. Manufacturing Process Analysis of Dermatophytic Onychomycosis
Figure 69. Dermatophytic Onychomycosis Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
